Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2011)
Assembly Biosciences (ASMB) recorded quarterly Interest Coverage Ratio of 62.47 in Q4 2011, up 419.82% quarter-over-quarter from 19.53 in Q3 2011, and up 4392.14% on a YoY basis from 1.39 in Q4 2010.
Assembly Biosciences (ASMB) Interest Coverage Ratio (2010 - 2011) Analysis & Trends
Assembly Biosciences' Interest Coverage Ratio history runs 2 years deep, the most recent figure standing at 62.47 for Q4 2011.
- In Q4 2011, Interest Coverage Ratio rose 4392.14% year-over-year to 62.47; the TTM figure through Sep 2012 stood at 132.06 (up 1250.58% YoY), while the FY2011 annual figure was 291.45, down 12396.93% from the prior year.
- Interest Coverage Ratio was 62.47 for Q4 2011 at Assembly Biosciences, up from 19.53 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 62.47 in Q4 2011 to a low of 104.72 in Q2 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Assembly Biosciences | 418.96 Mn | 192.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 62.47 |
| Sep 30, 2011 | -19.53 |
| Jun 30, 2011 | -104.72 |
| Mar 31, 2011 | -59.71 |
| Dec 31, 2010 | 1.39 |
| Sep 30, 2010 | -0.40 |
| Jun 30, 2010 | -0.96 |